Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Distinct spatial requirement for eosinophil-induced airways hyperreactivity.

D C Webb1, A N McKenzie, K I Matthaei

  • 1Leukocyte Signalling and Regulation Laboratory, Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Australian Capital Territory, Australia.

Immunology and Cell Biology
|March 27, 2001
PubMed
Summary

Targeting interleukin-5 (IL-5) and eotaxin is crucial for asthma immunotherapy, as they are key in eosinophil recruitment and airways hyperreactivity. Depleting IL-4 and IL-13 alone is insufficient to resolve allergic lung inflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-GeV Electron Acceleration in Wakefields Strongly Driven by Oversized Laser Spots.

Physical review letters·2024
Same author

Ultrafast Imaging of Laser Driven Shock Waves using Betatron X-rays from a Laser Wakefield Accelerator.

Scientific reports·2018
Same author

Esophageal IgG4 levels correlate with histopathologic and transcriptomic features in eosinophilic esophagitis.

Allergy·2018
Same author

Enhanced Laser-Driven Ion Acceleration by Superponderomotive Electrons Generated from Near-Critical-Density Plasma.

Physical review letters·2018
Same author

Advancing the management of obstructive airways diseases through translational research.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2018
Same author

IL-33 is induced in undifferentiated, non-dividing esophageal epithelial cells in eosinophilic esophagitis.

Scientific reports·2017

Area of Science:

  • Immunology
  • Allergy and Asthma Research
  • Pulmonary Medicine

Background:

  • T helper 2 (Th2) cytokines orchestrate asthma pathogenesis by recruiting inflammatory cells like eosinophils.
  • The role of eosinophils in asthma-related airways hyperreactivity (AHR) is debated.
  • Understanding cytokine requirements for eosinophil recruitment and AHR is vital for developing effective asthma therapies.

Purpose of the Study:

  • To define the roles of IL-4, IL-13, IL-5, and eotaxin in eosinophil recruitment and AHR in a murine model of allergic pulmonary disease.
  • To evaluate the necessity of IL-4 and IL-13 for eosinophilia and AHR.
  • To determine the combined requirement of IL-5 and eotaxin for eosinophil trafficking and AHR.

Main Methods:

  • Utilized a murine model of allergic pulmonary disease.

Related Experiment Videos

  • Investigated the effects of depleting IL-4, IL-13, IL-5, and eotaxin on pulmonary eosinophilia and AHR.
  • Compared inflammatory profiles in mice with deficiencies in different cytokine combinations.
  • Main Results:

    • Depletion of both IL-4 and IL-13 was necessary to abolish pulmonary eosinophilia and AHR.
    • IL-4 and IL-13 regulate the expression of IL-5 and eotaxin.
    • A deficiency in both IL-5 and eotaxin was required to eliminate eosinophil trafficking to the lung and AHR.
    • Inflammation was significantly attenuated in mice deficient in IL-5 and eotaxin compared to those deficient in IL-4 and IL-13.

    Conclusions:

    • Asthma immunotherapy may be more effective when targeting IL-5 and eotaxin rather than the broader IL-4 and IL-13.
    • IL-5 and eotaxin are critical downstream mediators for eosinophil recruitment and AHR in this asthma model.
    • IL-4 and IL-13 play a role in modulating alternative inflammatory responses beyond eosinophil pathways.